Last reviewed · How we verify

Panax Ginseng

Seoul National University Hospital · FDA-approved active Small molecule Under review

Panax Ginseng is a Herbal adaptogen / botanical extract Small molecule drug developed by Seoul National University Hospital. It is currently FDA-approved for Fatigue and weakness, Cognitive enhancement and mental performance, Immune support and stress adaptation. Also known as: Ginsana-115.

Panax ginseng contains ginsenosides and other bioactive compounds that modulate immune function, reduce inflammation, and enhance stress adaptation through multiple signaling pathways.

Panax Ginseng, also known as Asian Ginseng, is a plant whose root is used in various studies, including those on dry eye, reaction time, menstrual disorders, fibromyalgia, and chronic fatigue syndrome. However, the exact mechanism of action of Panax Ginseng is currently unknown.

At a glance

Generic namePanax Ginseng
Also known asGinsana-115
SponsorSeoul National University Hospital
Drug classHerbal adaptogen / botanical extract
ModalitySmall molecule
Therapeutic areaGeneral wellness, fatigue, cognitive function, immunomodulation
PhaseFDA-approved

Mechanism of action

Panax ginseng root extract acts as an adaptogen, helping the body resist physical and mental stress while promoting homeostasis. Its active constituents (ginsenosides, polysaccharides, and phenolic compounds) interact with multiple targets including immune cells, cytokine pathways, and stress hormone regulation. These mechanisms support energy metabolism, cognitive function, and overall resilience to fatigue and illness.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Panax Ginseng

What is Panax Ginseng?

Panax Ginseng is a Herbal adaptogen / botanical extract drug developed by Seoul National University Hospital, indicated for Fatigue and weakness, Cognitive enhancement and mental performance, Immune support and stress adaptation.

How does Panax Ginseng work?

Panax ginseng contains ginsenosides and other bioactive compounds that modulate immune function, reduce inflammation, and enhance stress adaptation through multiple signaling pathways.

What is Panax Ginseng used for?

Panax Ginseng is indicated for Fatigue and weakness, Cognitive enhancement and mental performance, Immune support and stress adaptation, General wellness and vitality.

Who makes Panax Ginseng?

Panax Ginseng is developed and marketed by Seoul National University Hospital (see full Seoul National University Hospital pipeline at /company/seoul-national-university-hospital).

Is Panax Ginseng also known as anything else?

Panax Ginseng is also known as Ginsana-115.

What drug class is Panax Ginseng in?

Panax Ginseng belongs to the Herbal adaptogen / botanical extract class. See all Herbal adaptogen / botanical extract drugs at /class/herbal-adaptogen-botanical-extract.

What development phase is Panax Ginseng in?

Panax Ginseng is FDA-approved (marketed).

What are the side effects of Panax Ginseng?

Common side effects of Panax Ginseng include Insomnia or sleep disturbance, Headache, Gastrointestinal upset, Nervousness or anxiety, Hypertension (in susceptible individuals).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing